The global microbial identification market size is valued at USD 1.62 billion in 2021 and is expected to reach USD 2.19 billion by 2026 with a CAGR of 6.3% during the forecast period.
Microbial identification entails identifying various kinds of microorganisms that are prone to cause different infectious conditions in humans. In the present world, the major types of microorganisms that cause diseases are parasites, bacteria, fungi, and viruses. Their presence contaminates the manufacturing facilities, raw materials, and food products.
The global microbial identification market is expected to be driven by the increasing incidence of infectious diseases and increasing food safety concerns worldwide. Governments, private institutes, agricultural producers, water treatment plants, alcohol manufacturers, and other research laboratories use microbial detection extensively. Furthermore, government initiatives and increasing healthcare spending are projected to drive the global microbial identification market in the coming years. The rapid advancements in the field of microbiology have helped the global microbial identification market's expansion. Also, the collaboration between pharmacy and medical intervention in the regional markets encourages regional market expansion.
The global microbial identification market is further driven by ongoing technological advances in precise precision and speed of microbial identification equipment and an increase in the number of diseases caused by harmful microorganisms, and strict food protection regulations. Several scientific advances based on basic molecular methods have been available on the market for the past few years. These technologies, especially peptide nucleic acid fluorescent in situ hybridization (PNA-FISH) and targeted real-time PCR, such as GeneXpert assays, help in microbial identification and have the potential to save money. In addition, the increasing investments by the government and private organizations more likely to encourage the market microbial identification market.
Automated microbial detection devices are more expensive, and they have more sophisticated features and functions—a MALDI-TOF-based device costs. The consumables used in identification procedures are often costly, as is the work involved. Many recent rapid experiments are also required higher capital, which is considerably higher than traditional culture approaches. The average cost of tools, media, and labor is disproportionately high for specific end-users due to their small budgets; academic research laboratories cannot purchase such systems. The use of microbial detection methods generally requires the use of qualified professionals, and the lack of trained professionals impedes the development of the microbial sector. Microbial detection methods such as gene sequencing, for example, provide quick results but require money and trained personnel, restricting their use.
Impact of COVID-19 on the global microbial identification market:
The COVID-19 is an infectious disease that disrupted all sectors of the economy. The global economy has been severely affected due to the sudden outbreak. The world health organization announced the COVID-19 as the emergence of healthcare and imposed nationwide lockdown restrictions, and banned international flights. Since most of the countries are major manufacturers of the consumables and instruments used for microbial identification, sales of these products have been stopped due to nationwide lockdown; this has negatively affected the microbial identification market. However, the market is expected to have its normal growth in the next coming years.
Clinical Trials.gov reported that MALDI-TOF MS profiling had established an advanced PCR-free technique focused on identifying unique protein signatures in human saliva during the covid-19 timeframe. For the detection of microorganisms, MALDI-TOF MS profiling has been used in routine diagnostics. The MALDI-TOF MS profiling has been used to analyze individual’s infectious status based on their saliva.
Market Size Available
2021 to 2026
2021 to 2026
By Method, Application, Product, End User, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
Shimadzu Corporation, Dickinson & Company, Biolog Inc., Merck KGaA, IEH Laboratories & Consulting Group, Trivitron Healthcare, Thermo Fisher Scientific Inc., Bruker Corporation, VWR Corporation, and Charles River Laboratories International Inc.
This research report on the global microbial identification market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2026.
Microbial Identification Market - By Method:
Based on the method, the Phenotypic method segment is the dominating segment globally because of its accuracy over the traditionally utilized Genotypic method. Proteomics is the study of proteins on a large scale. Proteins are essential components of living organisms that have a variety of roles. Proteomics refers to the large-scale laboratory study of proteins and proteomes in general, but it is often used to refer to protein purification and mass spectrometry in general. Proteomics has accelerated due to advances in large-scale nucleotide sequencing of expressed gene tags and genomic DNA. Proteins could not be represented without this information, even with advances in MS.
Microbial Identification Market - By Application
Based on application, the Diagnostic segment is the leading segment according to the market share because of the globally increasing concern about health. However, the growing geriatric population, which has resulted in a rise in the prevalence of chronic and infectious diseases, contributes to the segment's growth.
Microbial Identification Market - By Product
Based on product, the instruments segment is the top market share contributor globally. The instrument segment growth is attributed to technological advancements in microbial identification, the proliferation of infectious diseases, growing food safety concerns, and prominent players worldwide.
Microbial Identification Market - By End User
Based on end-user, the Hospitals and Diagnostic Centres segment led the global market in 2019, owing to the high incidence of various microbial infections. The rising geriatric population base, demand for HAI diagnostics from middle and low-income countries, and technologically advanced diagnostic products are all factors moving the HAI diagnostics market forward.
Microbial Identification Market - By Region:
Due to the developed healthcare industry, the North American regions contributed to the global market in 2019. Because of the rising amount of money spent on healthcare in emerging countries in the region, the Asia Pacific market is calculated to grow with the highest growth rate.
KEY MARKET PARTICIPANTS:
Some of the notable companies operating in the globe microbial identification market profiled in the report are Shimadzu Corporation, Dickinson & Company, Biolog Inc., Merck KGaA, IEH Laboratories & Consulting Group, Trivitron Healthcare, Thermo Fisher Scientific Inc., Bruker Corporation, VWR Corporation, and Charles River Laboratories International Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.5 Y-o-Y Growth Analysis, By Method
5.1.6 Market Attractiveness Analysis, By Method
5.1.7 Market Share Analysis, By Method
5.2.6 Y-o-Y Growth Analysis, By Application
5.2.7 Market Attractiveness Analysis, By Application
5.2.8 Market Share Analysis, By Application
5.3.2 Identification Services
5.3.5 Y-o-Y Growth Analysis, By Products and Services
5.3.6 Market Attractiveness Analysis, By Products and Services
5.3.7 Market Share Analysis, By Products and Services
5.4 End User
5.4.1 Food Manufacturing Industries
5.4.2 Pharmaceutical Companies
5.4.3 Hospitals and Diagnostic Centres
5.4.4 Other End users
5.3.5 Y-o-Y Growth Analysis, By End User
5.3.6 Market Attractiveness Analysis, By End User
5.3.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Method
188.8.131.52 By Application
184.108.40.206 By Product
220.127.116.11 By End User
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Method
126.96.36.199 By Application
188.8.131.52 By Product
184.108.40.206 By End user
6.1.5 Market Share Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Method
22.214.171.124 By Application
126.96.36.199 By Product
188.8.131.52 By End user
6.2 North America
6.2.2 United States
6.4.6 South Korea
6.5 Latin America
6.5.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Shimadzu Corporation
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Dickinson & Company
8.3 Biolog Inc.
8.4 Merck KGaA
8.5 IEH Laboratories & Consulting Group
8.6 Trivitron Healthcare
8.7 Laboratory Corporation of America Holdings
8.8 Thermo Fisher Scientific Inc.
8.9 Bruker Corporation
8.10 Charles River Laboratories
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Request Sample to View LOT